These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1283569)

  • 1. Metabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.
    Balani SK; Pitzenberger SM; Kauffman LR; Arison BH; Ramjit HG; Goldman ME; O'Brien JA; King JD; Hoffman JM; Rooney CS
    Drug Metab Dispos; 1992; 20(6):869-76. PubMed ID: 1283569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
    Balani SK; Kauffman LR; Arison BH; Olah TV; Goldman ME; Varga SL; O'Brien JA; Ramjit HG; Rooney CS; Hoffman JM
    Drug Metab Dispos; 1994; 22(2):200-5. PubMed ID: 7516852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism.
    Prueksaritanont T; Dwyer LM; Balani SK; Theoharides AD
    Drug Metab Dispos; 1994; 22(2):281-8. PubMed ID: 7516854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
    Balani SK; Goldman ME; Kauffman LR; Varga SL; O'Brien JA; Smith SJ; Olah TV; Ramjit HG; Schorn TW; Pitzenberger SM
    Drug Metab Dispos; 1993; 21(4):598-604. PubMed ID: 7690697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.
    Prueksaritanont T; Balani SK; Dwyer LM; Ellis JD; Kauffman LR; Varga SL; Pitzenberger SM; Theoharides AD
    Drug Metab Dispos; 1995 Jul; 23(7):688-95. PubMed ID: 7587955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
    Potts W; van Horn R; Anderson K; Blake T; Garver E; Joseph G; Dreyer G; Shu A; Heys R; Fong KL
    Drug Metab Dispos; 1995 Aug; 23(8):799-805. PubMed ID: 7493545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pharmacokinetics and tolerability of L-697,639, a non-nucleoside HIV-1 reverse transcriptase inhibitor.
    Van Hecken A; Depre M; De Lepeleire I; Laskin O; Au T; Woolf E; Yeh KC; De Schepper PJ
    Int J Clin Pharmacol Res; 1994; 14(2):45-50. PubMed ID: 7530697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 4. 3-[2-(Benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one and analogues.
    Hoffman JM; Smith AM; Rooney CS; Fisher TE; Wai JS; Thomas CM; Bamberger DL; Barnes JL; Williams TM; Jones JH
    J Med Chem; 1993 Apr; 36(8):953-66. PubMed ID: 7683054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 8. 8-Aryloxymethyl- and 8-arylthiomethyldipyridodiazepinones.
    Cywin CL; Klunder JM; Hoermann M; Brickwood JR; David E; Grob PM; Schwartz R; Pauletti D; Barringer KJ; Shih CK; Sorge CL; Erickson DA; Joseph DP; Hattox SE
    J Med Chem; 1998 Jul; 41(16):2972-84. PubMed ID: 9685236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor.
    McMahon JB; Buckheit RW; Gulakowski RJ; Currens MJ; Vistica DT; Shoemaker RH; Stinson SF; Russell JD; Bader JP; Narayanan VL; Schultz RJ; Brouwer WG; Felauer EE; Boyd MR
    J Pharmacol Exp Ther; 1996 Jan; 276(1):298-305. PubMed ID: 8558446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice.
    Chang M; Sood VK; Wilson GJ; Kloosterman DA; Sanders PE; Hauer MJ; Zhang W; Branstetter DG
    Drug Metab Dispos; 1997 Jul; 25(7):828-39. PubMed ID: 9224777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats.
    Chang M; Sood VK; Wilson GJ; Kloosterman DA; Sanders PE; Hauer MJ; Fagerness PE
    Drug Metab Dispos; 1997 Feb; 25(2):228-42. PubMed ID: 9029054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2(1H)-one.
    Saari WS; Wai JS; Fisher TE; Thomas CM; Hoffman JM; Rooney CS; Smith AM; Jones JH; Bamberger DL; Goldman ME
    J Med Chem; 1992 Oct; 35(21):3792-802. PubMed ID: 1279173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
    Goldman ME; Nunberg JH; O'Brien JA; Quintero JC; Schleif WA; Freund KF; Gaul SL; Saari WS; Wai JS; Hoffman JM
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6863-7. PubMed ID: 1713693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors.
    Goldman ME; O'Brien JA; Ruffing TL; Schleif WA; Sardana VV; Byrnes VW; Condra JH; Hoffman JM; Emini EA
    Antimicrob Agents Chemother; 1993 May; 37(5):947-9. PubMed ID: 7685996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.
    Le Van K; Cauvin C; de Walque S; Georges B; Boland S; Martinelli V; Demonté D; Durant F; Hevesi L; Van Lint C
    J Med Chem; 2009 Jun; 52(12):3636-43. PubMed ID: 19469474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150).
    Mellors JW; Im GJ; Tramontano E; Winkler SR; Medina DJ; Dutschman GE; Bazmi HZ; Piras G; Gonzalez CJ; Cheng YC
    Mol Pharmacol; 1993 Jan; 43(1):11-6. PubMed ID: 7678690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the metabolites of the HIV-1 reverse transcriptase inhibitor delavirdine in monkeys.
    Chang M; Sood VK; Kloosterman DA; Hauer MJ; Fagerness PE; Sanders PE; Vrbanac JJ
    Drug Metab Dispos; 1997 Jul; 25(7):814-27. PubMed ID: 9224776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and excretion of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo[3,2-d]-pyrimidin-4-one (SK3530) in rats.
    Lee J; Yoo HH; Rhim KJ; Sohn DR; Kim DH
    Rapid Commun Mass Spectrom; 2007; 21(7):1139-49. PubMed ID: 17318927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10,11-dimethyldihydropyran-12-ol ring (ring C).
    Zembower DE; Liao S; Flavin MT; Xu ZQ; Stup TL; Buckheit RW; Khilevich A; Mar AA; Sheinkman AK
    J Med Chem; 1997 Mar; 40(6):1005-17. PubMed ID: 9083491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.